HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF DOXACURIUM, A NEW LONG-ACTING NEUROMUSCULAR BLOCKER

被引:14
作者
DEANGELIS, R [1 ]
LOEBS, P [1 ]
MAEHR, R [1 ]
SAVARESE, J [1 ]
WELCH, R [1 ]
机构
[1] CORNELL UNIV,MED CTR,NEW YORK HOSP,SCH MED,DEPT ANESTHESIOL,NEW YORK,NY 10021
来源
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1990年 / 525卷 / 02期
关键词
D O I
10.1016/S0378-4347(00)83415-5
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid and sensitive high-performance liquid chromatographic procedure was developed for the analysis of the new, long-acting neuromuscular blocker doxacurium in the plasma and urine of dog and man and in the bile of dog. Samples were prepared on solid-phase extraction cartridges containing a methyl (C1) bonded phase and were chromatographed on a 15 cm reversed-phase column (C1) using a mobile phase of 0.05 M monobasic potassium phosphate-acetonitrile (30:70, v/v). The compound was detected at 210 nm with a lower limit of quantitation of 10 ng/ml. An inter-assay accuracy of 90-92% was obtained for the analysis of the drug from biological fluids. The method was applied to studies of doxacurium after intravenous administration to dog and man. © 1990.
引用
收藏
页码:389 / 400
页数:12
相关论文
共 18 条
[11]  
Reynolds D L, 1983, J Pharm Biomed Anal, V1, P347, DOI 10.1016/0731-7085(83)80047-8
[12]   THE CLINICAL NEUROMUSCULAR PHARMACOLOGY OF MIVACURIUM CHLORIDE (BW B1090U) - A SHORT-ACTING NONDEPOLARIZING ESTER NEUROMUSCULAR BLOCKING DRUG [J].
SAVARESE, JJ ;
ALI, HH ;
BASTA, SJ ;
EMBREE, PB ;
SCOTT, RPF ;
SUNDER, N ;
WEAKLY, JN ;
WASTILA, WB ;
ELSAYAD, HA .
ANESTHESIOLOGY, 1988, 68 (05) :723-732
[13]  
SAVARESE JJ, 1983, ANESTHESIOLOGY, V59, pA274
[15]   DETERMINATION OF ATRACURIUM, LAUDANOSINE AND RELATED-COMPOUNDS IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
SIMMONDS, RJ .
JOURNAL OF CHROMATOGRAPHY, 1985, 343 (02) :431-436
[16]  
STILLER RL, 1985, ANESTH ANALG, V64, P58
[17]  
WEATHERLEY BC, 1983, BRIT J ANAESTH, V55, pS39
[18]   CLINICAL-SIGNIFICANCE OF ESTERASES IN MAN [J].
WILLIAMS, FM .
CLINICAL PHARMACOKINETICS, 1985, 10 (05) :392-403